These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20208132)

  • 1. PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
    Heikaus S; Pejin I; Gabbert HE; Ramp U; Mahotka C
    Cell Oncol; 2010; 32(1-2):29-42. PubMed ID: 20208132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC.
    Heikaus S; Kempf T; Mahotka C; Gabbert HE; Ramp U
    Apoptosis; 2008 Jul; 13(7):938-49. PubMed ID: 18516683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly.
    Jang TH; Park HH
    BMB Rep; 2013 Sep; 46(9):471-6. PubMed ID: 24064063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reconstitution of the interactions in the PIDDosome.
    Jang TH; Zheng C; Wu H; Jeon JH; Park HH
    Apoptosis; 2010 Dec; 15(12):1444-52. PubMed ID: 20872280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-2 activation in the absence of PIDDosome formation.
    Manzl C; Krumschnabel G; Bock F; Sohm B; Labi V; Baumgartner F; Logette E; Tschopp J; Villunger A
    J Cell Biol; 2009 Apr; 185(2):291-303. PubMed ID: 19364921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas.
    Yan Y; Mahotka C; Heikaus S; Shibata T; Wethkamp N; Liebmann J; Suschek CV; Guo Y; Gabbert HE; Gerharz CD; Ramp U
    Br J Cancer; 2004 Oct; 91(7):1349-57. PubMed ID: 15328523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIDDosome-independent tumor suppression by Caspase-2.
    Manzl C; Peintner L; Krumschnabel G; Bock F; Labi V; Drach M; Newbold A; Johnstone R; Villunger A
    Cell Death Differ; 2012 Oct; 19(10):1722-32. PubMed ID: 22595758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
    Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
    Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topotecan (Hycamtin) responsiveness in human renal carcinoma cell lines of the clear cell and papillary types.
    Ramp U; Mahotka C; Kalinski T; Ebel E; Gabbert HE; Gerharz CD
    Anticancer Res; 2001; 21(5):3509-17. PubMed ID: 11848517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of neurodevelopmental disorders caused by pathogenic variants of PIDD.
    Ha HJ; Park HH
    Biochem Biophys Res Commun; 2023 Feb; 645():147-153. PubMed ID: 36689811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of caspase activation and apoptosis in renal tubular epithelial cells and renal cell carcinomas.
    Davidson K; Percy C; Rennick AJ; Pat BK; Li J; Nicol D; Johnson DW; Gobe GC
    Nephron Exp Nephrol; 2005; 99(4):e112-20. PubMed ID: 15711100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome.
    Taghiyev AF; Guseva NV; Glover RA; Rokhlin OW; Cohen MB
    Cancer Biol Ther; 2006 Sep; 5(9):1199-205. PubMed ID: 17110788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus.
    Ando K; Parsons MJ; Shah RB; Charendoff CI; Paris SL; Liu PH; Fassio SR; Rohrman BA; Thompson R; Oberst A; Sidi S; Bouchier-Hayes L
    J Cell Biol; 2017 Jun; 216(6):1795-1810. PubMed ID: 28432080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total recall: the role of PIDDosome components in neurodegeneration.
    Volik PI; Kopeina GS; Zhivotovsky B; Zamaraev AV
    Trends Mol Med; 2023 Dec; 29(12):996-1013. PubMed ID: 37716905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
    Hasegawa H; Yamada Y; Tsukasaki K; Mori N; Tsuruda K; Sasaki D; Usui T; Osaka A; Atogami S; Ishikawa C; Machijima Y; Sawada S; Hayashi T; Miyazaki Y; Kamihira S
    Leukemia; 2011 Apr; 25(4):575-87. PubMed ID: 21242994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of dominant negative mutants of RAIDD and PIDD.
    Jang TH; Bae JY; Park OK; Kim JH; Cho KH; Jeon JH; Park HH
    Biochim Biophys Acta; 2010 Jul; 1804(7):1557-63. PubMed ID: 20406701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD.
    Ribe EM; Jean YY; Goldstein RL; Manzl C; Stefanis L; Villunger A; Troy CM
    Biochem J; 2012 Jun; 444(3):591-9. PubMed ID: 22515271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.
    Peintner L; Dorstyn L; Kumar S; Aneichyk T; Villunger A; Manzl C
    Cell Death Differ; 2015 Nov; 22(11):1803-11. PubMed ID: 25857265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress.
    Tinel A; Tschopp J
    Science; 2004 May; 304(5672):843-6. PubMed ID: 15073321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of RAIDD death domain implicates potential mechanism of PIDDosome assembly.
    Park HH; Wu H
    J Mol Biol; 2006 Mar; 357(2):358-64. PubMed ID: 16434054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.